Terumo Corporation/テルモ株式会社
Terumo Corporation/テルモ株式会社 (Japan) holds 0 active US FDA Type II Drug Master Files and 1 inactive. 8 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Terumo Corporation/テルモ株式会社: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/terumo-corporation
Overview
Terumo Corporation/テルモ株式会社 is a medical device company headquartered in Hatagaya, Japan.
API / Drug Master Files
Terumo Corporation/テルモ株式会社 holds 0 active (1 total) FDA Type II Drug Master File. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- IHL- 305 IRINOTECAN LIPOSOME INJECTIONInactive2006-03-06
FDA compliance signals
8 FDA enforcement records linked to this company.
- 4832023-03-21
Aseptic Processing Area
- 4832023-03-21
Validation lacking for sterile drug products
- 4832023-03-21
Exhaust systems inadequate to control air contamination
- 4832023-03-21
Cleaning System
- 4832023-03-21
Authority lacking to review records, investigate errors
- 4832023-03-21
Computer control of master formula records
- 4832023-03-21
Habits of good sanitation & health
- 4832023-03-21
In-process conformity - examination, sample testing
Is this Terumo Corporation/テルモ株式会社?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.